Abstract
In vivo free radical imaging in pre-clinical models of disease is now possible. Free radicals have traditionally been characterized by ESR or EPR spin trapping spectroscopy. The disadvantage of the ESR/EPR approach is that spin adducts are short-lived due to biological reductive and/or oxidative processes. Immuno-spin trapping (IST) involves the use of an antibody that recognizes macromolecular DMPO-spin adducts (anti-DMPO antibody), regardless of the oxidative/reductive state of trapped radical adducts. The IST approach has been extended to an in vivo application that combines IST with molecular magnetic resonance imaging (mMRI). This combined IST-mMRI approach involves the use of a spin trapping agent, DMPO, to trap free radicals in disease models, and administration of a mMRI probe, an anti-DMPO probe, that combines an antibody against DMPO-radical adducts and a MRI contrast agent, resulting in targeted free radical adduct detection. The combined IST-mMRI approach has been used in several rodent disease models, including diabetes, ALS, gliomas, and septic encephalopathy. The advantage of this approach is that heterogeneous levels of trapped free radicals can be detected directly in vivo and in situ to pin-point where free radicals are formed in different tissues. The approach can also be used to assess therapeutic agents that are either free radical scavengers or generate free radicals. The focus of this review will be on the different applications that have been studied, advantages and limitations, and future directions.
Keywords
- immuno-spin trapping (IST)
- molecular magnetic resonance imaging (mMRI)
- targeted free radical imaging
- in vivo
- diabetes
- amyotrophic lateral sclerosis (ALS)
- glioma
- septic encephalopathy
- mice
- rats
1. Introduction
1.1. Free radicals in various diseases
Reactive oxygen and nitrogen species (RONS) lead to structural and functional modifications of cellular proteins and lipids, resulting in cellular dysfunction, such as impaired energy metabolism, altered cell signaling and cell cycle control, impaired cell transport processes and dysfunctional biological activities, immune activation, and inflammation [1]. RONS can be involved in several disease processes as causative agents or result as an effect of the pathogenesis. It is well known that free radicals play a role in the pathogenesis associated with various diseases such as diabetes, septic encephalopathy, neurodegenerative diseases, and cancers, to mention a few.
Nutritional stress, that for instance may result from excessive high-fat and/or carbohydrates, can promote oxidative stress, subsequently forming lipid peroxidation products, protein carbonylation, as well as decreased antioxidant levels [1]. Chronic oxidative stress and inflammation, both associated with obesity, can lead to insulin resistance, dysregulated metabolic pathways, diabetes and cardiovascular diseases, via impaired signaling and metabolism that result in insulin secretion dysfunction, insulin action, and immune responses [1]. In type 1 diabetes mellitus, RONS released from phagocytes may damage adjacent cells, which can lead to excessive inflammation and an autoimmune attack against pancreatic islet β-cells, and contribute to a rapid progression of pathogenesis [1]. Immune system-associated enzymes (such as NADPH oxidase) can trigger the formation of reactive oxygen species (ROS) [1]. Excessive glucose and lipid levels, endocrine factors and numerous pro-inflammatory cytokines are known to activate NADPH oxidase [1]. Pro-inflammatory cytokines can also upregulate nitric oxide synthase 2 (NOS2), producing excessive nitric oxide, which can subsequently lead to the formation of peroxynitrite, and lead to further oxidative stress [1]. In Type 2 diabetes mellitus, excessive RONS production from chronic hyperglycemia increases oxidative stress in tissues that exacerbate the disease, such as pancreatic islets, muscle, adipose and hepatic, as well as influences secondary diabetic complications, including nephropathy, vascular disease and retinopathy, leading to oxidized lipids and proteins [1, 2].
Sepsis-associated encephalopathy pathophysiology is still poorly understood, but a number of mechanisms-of-action (MOA) have been proposed, including mitochondrial and vascular dysfunction, oxidative damage, neurotransmission disturbances, inflammation, and cellular death [3, 4]. Oxidative stress is a central MOA of acute brain damage [3]. Systemic inflammation induces mitochondrial dysfunction, which is involved in both apoptotic and necrotic cell death pathways, and increased glucose uptake by brain tissues, which results in the diversion of glucose to the pentose phosphate pathway that may contribute to oxidative stress by producing excessive superoxide radicals via NADPH oxidase [3, 4]. In addition, microglia activation results in the secretion of nitric oxide, ROS (reactive oxygen species) and matrix metalloproteinases (MMPs) that can all contribute to blood-brain barrier (BBB) and neuronal damage [3]. Regarding brain dysfunction in sepsis, it is thought that RONS, generated during a systemic inflammatory response, triggers lipid peroxidation due to a decreased antioxidant activity [4]. Free radical-induced structural membrane damage also induces neuro-inflammation [4]. The formation of excessive superoxide radicals also depletes ambient nitric oxide in the cerebrovascular bed, forming peroxynitrite, which irreversibly inhibits the mitochondrial electron transport chain, resulting in an increase in mitochondrial release of free radicals, and leads to mitochondrial dysfunction and neuronal bioenergetics failure [4]. Additionally, free radicals trigger apoptosis via altering intracellular calcium homeostasis in brain regions such as the cerebral cortex and hippocampus, further exacerbating local inflammatory responses further [4].
Oxidative stress has been proposed as a contributory factor in the pathogenesis of several neurodegenerative diseases [5]. For instance, in familial ALS (amyotrophic lateral sclerosis) (accounting for 5–10% of ALS cases) there is a mutation in superoxide dismutase 1 (SOD1) which results in dysfunctional superoxide radical clearance, leading to increased oxidative stress [5]. NADPH oxidases have emerged as possible drug targets for the treatment of neurodegeneration, due to their role in generating oxidants and also regulating microglia activation [6].
In cancer cells, RONS accumulation can result in damaging DNA, directly through an increase in cellular mutations and/or increase in oncogenic phenotypes, or indirectly by acting as secondary messengers intracellular signaling cascades [7]. It is thought that impaired cellular repair mechanisms induced by RONS oxidative stress on DNA can lead to cell injury and subsequently to genomic instability, mutagenesis and tumorigenesis [7]. It is also known that ROS can promote cell proliferation activating growth-related signaling pathways [7]. ROS may be involved in the multistep oncogenesis process at various different phases related to tumor initiation and progression, ROS-related mechanisms during tumor promotion, maintenance of the transformed state through extracellular superoxide radical formation by NADPH oxidase 1, and resistance to oxidative stress signals through membrane-associated catalase expression [7].
1.2. Spin trapping and ESR/EPR spectroscopy
For over half a century, free radicals were characterized by electron spin resonance (ESR) or electron paramagnetic resonance (EPR) spectroscopy coupled with spin trapping. Nitrone spin traps (
The disadvantage of the ESR/EPR approach is that the spin adducts (spin trapping agent — free radical adducts or aminoxyls) are short-lived due to reductive and/or oxidative processes in biological systems [8, 9] (see Figure 1).
1.3. Immuno-spin trapping (IST)
Mason
1.4. Combined IST and molecular MRI (mMRI) detection of in vivo and in situ free radicals
Towner
1.5. Other approaches used to detect in vivo and in situ free radicals in animal models and cells
It is well known that intensity-based fluorescent methods (particularly 2′,7′-dicholorofluorescin [DCFH]) for ROS (includes the non-radical hydrogen peroxide) detection/quantification are sensitive and readily used, however, these agents lack the specificity for ROS or reactive nitrogen species (RNS), and often produce artifacts resulting in false-positive signals [35, 36]. An interesting recent study by Liu et al. used a new fluorescent probe, MPT-Cy2, which can be used to detect endogenous
Another group, Li et al. used a near infrared (NIR)-light excited luminescence resonance energy transfer based nanoprobe for
Rayner et al. used a reversible pro-fluorescent probe containing a redox sensitive nitroxide moiety (methyl ester tetraethylrhodamine nitroxide, ME-TRN) for the
Recent studies by Berkowitz et al. have used quench-assisted (Quest) 1/T1 MRI to measure oxidative stress changes in rodent models [49, 50]. Quest MRI detected pathologic free radical production in MnSOD (manganese superoxide dismutase) knockout mouse retinas with laminar resolution
Endogenous reactive oxygen species (ROS) contrast MRI was also recently used by Tain et al. to detect ROS (measured as a reduction in T1) in rotenone-treated mouse brains [51]. Another study by Eto et al. used
1.6. Overall scope
The focus of this review is on
2. In vivo and In situ targeted free radical detection: various models
The combined IST-mMRI approach has been used in several
2.1. Diabetes
The initial proof-of-concept combined IST and mMRI approach to detect
At a later stage it was found that the cardiac muscle in diabetic mice also retained the anti-DMPO probe [30] (see Figure 6). A morphological MR image of a mouse heart is shown in Figure 6A. The post-contrast minus pre-contrast image in a diabetic mouse with false coloration is shown in Figure 6A, overlaid on top of a horizontal morphological image of the heart.
Significantly higher quantitative levels of the anti-DMPO probe in diabetic (Diab) mice administered DMPO (D) and the anti-DMPO probe (P) were found when compared to diabetic (administered the isotype IgG contrast agent instead of the anti-DMPO probe) and non-diabetic (non-STZ exposed WT mice administered DMPO and the anti-DMPO probe) controls (see Figure 6B). Confirmation of the presence of the anti-DMPO probe in cardiac muscle of a diabetic mouse is shown in Figure 6C. Verification of the presence of DMPO-radical adducts is shown in Figure 6D, where a fluorescent-labeled anti-DMPO antibody was used. In the diabetic cardiomyopathy study, it was also established that diabetic mice had significantly higher levels of 3-nitrotyrosine (3-NT) (oxidized protein marker) (Figure 6E) and malondialdehyde (MDA) adducts (oxidized lipid marker) (Figure 6F) in cardiac muscle, when compared to non-diabetic mice. This was the first
2.2. Septic encephalopathy
It was then decided to assess the combined IST and mMRI free radical-targeted approach in other disease models, such as septic encephalopathy. Mice with septic encephalopathy (induced by cecal ligation and puncture (CLP)) were also found to have higher levels of trapped DMPO-radical adducts compared to sham animals (abdominal incision without CLP and sutured) [31] (Figure 7). Figure 7A depicts a MRI SI difference image (false-colored red) overlaid on top of a morphological image of the brain region of a septic mouse. Confirmation of the presence of the anti-DMPO in the cortical brain tissue of a septic mouse is shown in Figure 7B, and verification of DMPO-radical adducts in a septic mouse brain is depicted in Figure 7C. The distribution of the anti-DMPO probe is dispersed throughout the brain, and was found to be significantly higher in septic mice vs. sham animals in the hippocampus, striatum, occipital lobe and medial cortex regions of the brain (Figure 7D), as measured by a % change (overall decrease in T1 relaxation). Oxidized lipid levels (measured from Western blots for 4-hydroxynonenal (4-HNE) (Figure 7E) and oxidized protein levels (measured from Western blots for 3-NT) (Figure 7F) were found to be significantly higher in septic mice (CLP) after 6 hours, compared to sham controls. This study also indicates that both oxidized lipids and proteins may play a role in the free radical-associated pathology of ALS. This is the first reported
2.3. Amyotrophic lateral sclerosis (ALS)
The combined IST and mMRI approach for detecting
2.4. Gliomas
Lastly, the combined IST and mMRI
The combined IST and mMRI approach in glioma models can also be used to assess possible therapeutic agents that are either free radical scavengers or generate free radicals. For example, this approach was used to assess the free radical scavenging ability of an anti-cancer agent, OKN-007, in a rat glioma model [34] (see Figure 9). Representative difference images (false-colored red) of an untreated F98 glioma and an OKN-007-treated F98 glioma, overlaid over appropriate morphological images, are shown in Figure 9A and B, respectively. Quantitative levels of trapped free radical levels (measured from % changes in MRI signal intensities) for untreated and OKN-007-treated F98 gliomas is shown in Figure 9C. Significantly lower levels of MDA (Figure 9F) and 3-NT (Figure 9G) were found for F98 gliomas treated with OKN-007 compared to untreated (UT) tumors. IHC levels for MDA and 3-NT were quantitated in several OKN-007-treated and UT F98 tumor-bearing rats. These results indicate that OKN-007 acts as a free radical scavenger when used as an anti-cancer agent. This is the first time
Immuno-electron microscopy (IEM) with gold-anti-biotin, targeting the biotin moiety of the anti-DMPO probe, was also used to confirm the
3. Concluding statements
The novelty of the IST-mMRI approach is that heterogeneous levels of trapped free radicals can be detected directly
This review has discussed all of the current studies that have utilized combined IST and mMRI to detect targeted trapped macromolecular DMPO-radical adducts
Some of the disadvantages with the methodology include limited access to pre-clinical MRI systems, availability of the anti-DMPO antibody, and further identifying the radical source that is being trapped. For non-neurological studies, this approach can be easily utilized in numerous pathological/toxicological models. However, for neurological studies, the approach will be limited to whether there is BBB permeability, in order to allow the anti-DMPO probe, and possibly DMPO, to access the target tissue.
The IST-mMRI approach can certainly be further applied to study free radicals associated longitudinally in oxidative stress-related disease processes, as well as assess the effect of therapeutic agents that alter free radical levels. Mass spectrometry may need to be used to not only further assess whether the anti-DMPO probe detected in heterogeneous tissue regions are essentially oxidized proteins or oxidized lipids, or a combination of both, before the type of protein or lipid is identified. The current size of the probe may prohibit use in neurological studies with an intact blood-brain barrier (BBB). The development of a smaller nanoparticle-based anti-DMPO probe, which may allow access through an intact BBB, is currently being considered.
References
- 1.
Newsholme P, Cruzat VF, Keane KN, Carlessi R, Homen de Bittencourt PI Jr. Molecular mechanisms of ROS production and oxidative stress in diabetes. The Biochemical Journal. 2016; 473 :4527-4550 - 2.
Fakhruddin S, Alanzi W, Jackson KE. Diabetes-induced reactive oxygen species: Mecha-nism of their generation and role in renal injury. Journal of Diabetes Research. 2017; 2017 :8379327 - 3.
Bozza FA, D’Avila JC, Ritter C, Sonneville R, Sharshar T, Dal-Pizzol F. Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock. 2013; 39 :10-16 - 4.
Berg RMG, Moller K, Bailey DM. Neuro-oxidative-nitrosative stress in sepsis. Journal of Cerebral Blood Flow and Metabolism. 2011; 31 :1532-1544 - 5.
Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M. Oxidative stress in neurodegenerative diseases. Molecular Neurobiology. 2016; 53 :4094-4125 - 6.
Sorce S, Stocker R, Seredenina T, Holmdahl R, Aguzzi A, Chio A, Depaulis A, Heitz F, Olosson P, Olsson T, Duveau V, Sanoudou D, Skosgater S, Vlahou A, Wasquel D, Krause KH, Jaquet V. NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence? Free Radical Biology & Medicine. 2017; 112 :387-396 - 7.
Rinaldi M, Caffo M, Minutoli L, Marini H, Abbritti RV, Squadrito F, Trichilo V, Valenti A, Barresi V, Altavilla D, Passalacqua M, Caruso G. ROS and brain gliomas: An overview of potential and innovative therapeutic strategies. International Journal of Molecular Sciences. 2016; 17 (6). Pii: E984. DOI: 10.3390/ijms17060984 - 8.
Towner RA. In: Rhodes C, editor. Chemistry of Spin Trapping, in Toxicology of the Human Environment: The Critical Role of Free Radicals. London: Taylor and Francis; 2000. pp. 7-24 - 9.
Janzen EG. Spin trapping. Methods in Enzymology. 1984; 104 :188-198 - 10.
Janzen EG, Stronks HJ, Dubose CM, Poyer JL, McCay PB. Chemistry and biology of spin-trapping radicals associated with halocarbon metabolism in vitro and in vivo. Environmental Health Perspectives. 1985; 64 :151-170 - 11.
Buettner GR. Spin trapping: ESR parameters of spin adducts. Free Radical Biology & Medicine. 1987; 3 :259-303 - 12.
McCay PB. Application of ESR spectroscopy in toxicology. Archives of Toxicology. 1987; 60 :133-137 - 13.
Janzen EG, Poyer JL, Schaefer CF, Downs PE, DuBose CM. Biological spin trapping. II. Toxicity of nitrone spin traps: Dose-ranging in the rat. Journal of Biochemical and Biophysical Methods. 1995; 30 :239-247 - 14.
Davies MJ, Slater TF. The use of electron-spin-resonance techniques to detect free-radical formation and tissue damage. The Proceedings of the Nutrition Society. 1988; 47 :397-405 - 15.
Villamena FA, Zweier JL. Detection of reactive oxygen and nitrogen species by EPR spin trapping. Antioxidants & Redox Signaling. 2004; 6 :619-629 - 16.
Hawkins CL, Davies MJ. Detection and characterisation of radicals in biological materials using EPR methodology. Biochimica et Biophysica Acta. 2014; 1840 :708-721 - 17.
Barriga-González G, Olea-Azar C, Zuñiga-López MC, Folch-Cano C, Aguilera-Venegas B, Porcal W, González M, Cerecetto H. Spin trapping: An essential tool for the study of diseases caused by oxidative stress. Current Topics in Medicinal Chemistry. 2015; 15 :484-495 - 18.
Davies MJ. Detection and characterisation of radicals using electron paramagnetic resonance (EPR) spin trapping and related methods. Methods. 2016; 109 :21-31 - 19.
Mason RP. Assay of in situ radicals by electron spin resonance. Methods in Enzymology. 1984;105 :416-422 - 20.
Mason RP. In: Rhodes C, editor. In vivo Spin Trapping – From Chemistry to Toxicology, in Toxicology of the Human Environment: The Critical Role of Free Radicals. London: Taylor and Francis; 2000. pp. 49-70 - 21.
Berliner LJ, Khramtsov V, Fujii H, Clanton TL. Unique in vivo applications of spin traps. Free Radical Biology & Medicine. 2011; 30 :489-499 - 22.
Berliner LJ. From spin-labeled proteins to in vivo EPR applications. European Biophysics Journal. 2010;39 :579-588 - 23.
Mason RP. Using anti-5,5-dimethyl-1-pyrroline N-oxide (anti-DMPO) to detect protein radicals in time and space with immuno-spin trapping. Free Radical Biology & Medicine. 2004; 36 :1214-1223 - 24.
Ramirez DC, Mason RP. Immuno-spin trapping: Detection of protein-centered radicals. Current Protocols in Toxicology. 2005; 17 :17 - 25.
Gomez-Mejiba SE, Zhai Z, Akram H, Deterding LJ, Hensley K, Smith N, Towner RA, Tomer KB, Mason RP, Ramirez DC. Immuno-spin trapping of protein and DNA radicals: “Tagging” free radicals to locate and understand the redox process. Free Radical Biology & Medicine. 2009; 46 :853-865 - 26.
Khoo NK, Cantu-Medellin N, St Croix C, Kelley EE. In vivo immuno-spin trapping: Imaging the footprints of oxidative stress. Current Protocols in Cytometry. 2015;74 :12.42.1-12.4211 - 27.
Mason RP. Imaging free radicals in organelles, cells, tissue, and in vivo with immuno-spin trapping. Redox Biology. 2016;8 :422-429 - 28.
Gomez-Mejiba SE, Zhai Z, Della-Vedova MC, Muñoz MD, Chatterjee S, Towner RA, Hensley K, Floyd RA, Mason RP, Ramirez DC. Immuno-spin trapping from biochemistry to medicine: Advances, challenges, and pitfalls. Focus on protein-centered radicals. Biochimica et Biophysica Acta. 2014; 1840 (2):722-729 - 29.
Towner RA, Smith N, Saunders D, Henderson M, Downum K, Lupu F, Silasi-Mansat R, Ramirez DC, Gomez-Mejiba SE, Bonini MG, Ehrenshaft M, Mason RP. In vivo imaging of immuno-spin trapped radicals with molecular MRI in a mouse diabetes model. Diabetes. 2012;61 :2405-2413 - 30.
Towner RA, Smith N, Saunders D, Carrizales J, Lupu F, Silasi-Mansat R, Ehrenshaft M, Mason RP. In vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice. Free Radical Research. 2015;49 :1140-1146 - 31.
Towner RA, Garteiser P, Bozza F, Smith N, Saunders D, d’Avila JCP, Magno F, Oliveira MF, Ehrenshaft M, Lupu F, Silasi-Mansat R, Ramirez DC, Gomez-Mejiba SE, Mason RP, Faria-Neto HCC. In vivo detection of free radicals in mouse septic encephalopathy using molecular MRI and immuno-spin-trapping. Free Radical Biology & Medicine. 2013;65 :828-837 - 32.
Towner RA, Smith N, Saunders D, Lupu F, Silasi-Mansat R, West M, Ramirez DC, Gomez-Mejiba SE, Bonini MG, Mason RP, Ehrenshaft M, Hensley K. In vivo detection of free radicals using molecular MRI and immuno-spin-trapping in a mouse model for amyotrophic lateral sclerosis (ALS). Free Radical Biology and Medicine. 2013;63 :351-360 - 33.
Towner RA, Smith N, Saunders D, De Souza PC, Henry L, Lupu F, Silasi-Mansat R, Ehrenshaft M, Mason RP, Gomez-Mejiba SE, Ramirez DC. Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas. Biochimica et Biophysica Acta. 2013;1832 :2153-2161 - 34.
Coutinho de Souza P, Smith N, Atolagbe O, Ziegler J, Nijoku C, Lerner M, Ehrenshaft M, Mason RP, Meek B, Plafker SM, Saunders D, Mamedova N, Towner RA. OKN-007 decreases free radicals levels in a preclinical F98 rat glioma model. Free Radical Biology & Medicine. 2015; 87 :157-168 - 35.
Ribou AC. Synthetic sensors for reactive oxygen species detection and quantification: A critical review of current methods. Antioxidants & Redox Signaling. 2016; 25 :520-533 - 36.
Bonini MG, Rota C, Tomasi A, Mason RP. The oxidation of 2′,7′-dichorofluorescin to reactive oxygen species: A self-fulfilling prophesy? Free Radical Biology & Medicine. 2006; 40 :968-975 - 37.
Liu F, Du J, Song D, Xu M, Sun G. A sensitive fluorescent sensor for the detection of endogenous hydroxyl radicals in living cells and bacteria and direct imaging with respect to its ecotoxicity in living zebra fish. Chemical Communications. 2016; 52 :4636-4639 - 38.
Hu JJ, Wong NK, Ye S, Chen X, Lu MY, Zhao AQ, Guo Y, Ma AC, Leung AY, Shen J, Yang D. Fluorescent probe HKSOX-1 for imaging and detection of endogenous superoxide in live cells and in vivo . Journal of the American Chemical Society. 2015;137 :6837-6843 - 39.
Liu X, Liu S, Liang G. Fluorescence turn-on for the highly selective detection of nitric oxide in vitro and in living cells. Analyst. 2016;141 :2600-2605 - 40.
Gupta N, Reja SI, Bhalla V, Gupta M, Kaur G, Kumar M. An approach for the selective detection of nitric oxide in biological systems: An in vitro andin vivo perspective. Chemistry, an Asian Journal. 2016;11 :1020-1027 - 41.
Iverson NM, Strano MS, Wogan GN. In vivo delivery of nitric oxide-sensing, single-walled carbon nanotubes. Current Protocols in Chemical Biology. 2015;7 :93-102 - 42.
Li Z, Liang T, Lv S, Zhuang Q, Liu Z. A rationally designed upconversion nanoprobe for in vivo detection of hydroxyl radical. Journal of the American Chemical Society. 2015;137 :11179-11185 - 43.
Huang Y, Yu F, Wang J, Chen L. Near-infrared fluorescence probe for in situ detection of superoxide anion and hydrogen polysulfides in mitochondrial oxidative stress. Analytical Chemistry. 2016;88 :4122-4129 - 44.
Zhang J, Li C, Zhang R, Zhang F, Liu W, Liu X, Le SM-Y, Zhang H. A phosphinate-based near-infrared fluorescence probe for imaging the superoxide radical anion in vitro andin vivo . Chemical Communications. 2016;52 :2679-2682 - 45.
Iverson NM, Barone PW, Shandell M, Trudel LJ, Sen S, Sen F, Ivanov V, Atolia E, Farias E, McNicholas TP, Reuel N, Parry NM, Wogan GN, Strano MS. In vivo biosensing via tissue-localizable near-infrared-fluorecent single-walled carbon nanotubes. Nature Nanotechnology. 2013;8 :873-880 - 46.
Shvedova AA, Kisin ER, Murray AR, Mouithys-Mickalad A, Stadler K, Mason RP, Kadiiska M. ESR evidence for in vivo formation of free radicals in tissue of mice exposed to single-walled carbon nanotubes. Free Radical Biology & Medicine. 2014;73 :154-165 - 47.
Rayner CL, Gole GA, Bottle SE, Barnett NL. Dynamic, in vivo , real-time detection of retinal oxidative status in a model of elevated intraocular pressure using a novel, reversibly responsive, profluorescent nitroxide probe. Experimental Eye Research. 2014;129 :48-56 - 48.
Du L, Huang S, Zhuang Q, Jia H, Rockenbauer A, Liu Y, Liu KJ, Liu Y. Highly sensitive free radical detection by nitrone-functionalized gold nanoparticles. Nanoscale. 2014; 6 :1646-1652 - 49.
Berkowitz BA, Lewin AS, Biswal MR, Bredell BX, Davis C, Roberts R. MRI of retinal free radical production with laminar resolution in vivo. Investigative Ophthalmology & Visual Science. 2016; 57 :577-585 - 50.
Berkowitz BA, Lenning J, Khetarpal N, Tran C, Wu JY, Berri AM, Dernay K, Haacke EM, Shafie-Khorassani F, Podolsky RH, Gant JC, Maimaiti S, Thibault O, Murphy GG, Bennett BM, Roberts R. In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome. The FASEB Journal. 2017. Epub ahead of print. DOI: 10.1096/fj.201700229R - 51.
Tain RW, Scotti AM, Li W, Zhou XJ, Cai K. Imaging short-lived reactive oxygen species (ROS) with endogenous contrast MRI. Journal of Magnetic Resonance Imaging. 2017. Epub ahead of print. DOI: 10.1002/jmri.25763 - 52.
Jerome NP, Papoutsaki MV, Orton MR, Parkes HG, Winfield JM, Boss MA, Leach MO, deSouza NM, Collins DJ. Development of a temperature-controlled phantom for magnetic resonance quality assurance of diffusion, dynamic, and relaxometry measurements. Medical Physics. 2016; 43 :2998 - 53.
Spear JT, Gore JC. New insights into rotating frame relaxation at high field. NMR in Biomedicine. 2016; 29 :1258-1273 - 54.
Eto H, Hyodo F, Kosem N, Kobayashi R, Yasukawa K, Nakao M, Kiniwa M, Utsumi H. Redox imaging of skeletal muscle using in vivo DNP-MRI and its application to an animal model of local inflammation. Free Radical Biology & Medicine. 2015; 89 :1097-1104 - 55.
Janzen EG, Towner RA. Aminoxyl radicals as MRI contrast agents. In: Zhdanov R, editor. Bioactive Spin Labels. Berlin: Springer-Verlag; 1992. pp. 573-583 - 56.
Hyodo F, Ito S, Eto H, Nakaji T, Yasukawa K, Kobayashi R, Utsumi H. Development of redox metabolic imaging using endogenous molecules. Yakugaku Zasshi. 2016; 136 :1107-1114 - 57.
Utsumi H, Hyodo F. Free radical imaging using in vivo dynamic nuclear polarization-MRI. Methods in Enzymology. 2015; 564 :553-571 - 58.
Ichikawa K, Yasukawa K. Imaging in vivo redox status in high spatial resolution with OMRI. Free Radical Research. 2012; 46 :1004-1010 - 59.
Yamamoto S, Watabe T, Ikeda H, Ichikawa K, Nakao M, Kato K, Hatazawa J. Development of a PET/OMRI combined system for simultaneous imaging of positron and free radical probes for small animals. Medical Physics. 2016; 43 :5676